Table 2.
Femoral Trabecular Parameters as Evaluated by MicroCT
| Treatment Group |
P Value |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 mo |
9 mo |
Time | Tx | 3 mo vs 9 mo |
Saline vs Fluoxetine |
|||||
| Saline (n = 7) | Fluoxetine (n = 7) | Saline (n = 8) | Fluoxetine (n = 7) | Saline | Fluoxetine | 3 mo | 9 mo | |||
| BV/TV, % | 3.5 ± 0.4 | 2.4 ± 0.4 | 1.4 ± 0.3 | 0.9 ± 0.2 | < 0.0001 | 0.02 | < 0.0001 | 0.0004 | 0.05 | 0.17 |
| Tb.N, 1/mm | 2.61 ± 0.08 | 2.54 ± 0.14 | 1.72 ± 0.07 | 1.74 ± 0.10 | < 0.0001 | 0.77 | < 0.0001 | < 0.0001 | 0.62 | 0.92 |
| Tb.S, μm | 0.38 ± 0.01 | 0.40 ± 0.03 | 0.58 ± 0.03 | 0.59 ± 0.04 | < 0.0001 | 0.87 | < 0.0001 | < 0.0001 | 0.80 | 0.98 |
| Tb.Th, μm | 0.044 ± 0.002 | 0.038 ± 0.003 | 0.046 ± 0.002 | 0.047 ± 0.004 | 0.05 | 0.39 | 0.53 | 0.04 | 0.17 | 0.85 |
| Tiss.BMD, mg Hg/cm3 | 905 ± 17.06 | 904 ± 17.28 | 908 ± 8.09 | 903 ± 15.96 | 0.99 | 0.81 | 0.95 | 0.96 | 0.91 | 0.82 |
Abbreviations: Tb.N, trabecular number; Tb.S, trabecular spacing; Tb.Th, trabecular thickness; Tiss.BMD, tissue bone mineral density; Tx, treatment.